Ultra-rapid lispro improved postprandial glucose control compared to insulin lispro in predominantly Chinese patients with type 1 diabetes: A prospective, randomized, double-blind phase 3 study.

Jianhua MaXiang YanQiong FengWei LiuFederico Pérez ManghiPedro García-HernándezGuixia WangJianwei XuYuan YuanZhiguang Zhou

Published in: Diabetes, obesity & metabolism (2023)

In this study, URLi administered in a basal-bolus regimen demonstrated superiority to insulin lispro in controlling PPG excursions, with noninferiority of HbA1c control in predominantly Chinese patients with T1D.

Keyphrases

type diabetes
double blind
blood glucose
placebo controlled
glycemic control
clinical trial
open label
high resolution
randomized controlled trial
study protocol
metabolic syndrome
blood pressure
skeletal muscle
phase iii
phase ii
insulin resistance